Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency

Tumor immunotherapy is only effective in a fraction of patients due to a low response rate and severe side effects, and these challenges of immunotherapy in clinics can be addressed through induction of immunogenic cell death (ICD). ICD is elicited from many antitumor therapies to release danger ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhilin, Lai, Xiaoqin, Fu, Shiqin, Ren, Long, Cai, Hao, Zhang, Hu, Gu, Zhongwei, Ma, Xuelei, Luo, Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353475/
https://www.ncbi.nlm.nih.gov/pubmed/35652198
http://dx.doi.org/10.1002/advs.202201734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353475/
https://www.ncbi.nlm.nih.gov/pubmed/35652198
http://dx.doi.org/10.1002/advs.202201734

Ejemplares similares